Intervention Insights provides genomics-based cancer treatment recommendations. A participant in the personalized medicine space, the company's OncInsights product is an information service for oncologists that matches a genetic analysis of a patient's tumor with the universe of drug therapies. read more »
MeQuilibrium provides a digital lifestyle management platform designed to provide customized support for individuals in uncovering, assessing, and managing the stresses in their lives. We are excited to back CEO Jan Bruce, who founded meQuilibrium in 2010 during her tenure as entrepreneur-in-residence at Chrysalis. read more »
CV's investment in XLerant reunites Chrysalis with one of its most successful entrepreneurs, CEO Ted Dacko. Dacko formerly served as CEO of HealthMedia, leading it to a successful acquisition by Johnson & Johnson in 2008 and delivering an almost 18x return to Chrysalis.
By taking over XLerant, Dacko returns to his roots in financial services (previously, Dacko was a senior executive at Hyperion, which was acquired by Oracle for over $300 million). read more »
A few highlights from our portfolio:
- HealthTeacher's products reach more than six million students in more than 20 states - some 10% of all schoolchildren in the United States.
- Foundation Radiology Group evaluated nearly 1 million medical images and quintupled sales in 2011.
- Regent Education successfully processed almost $100 million of student financial aid in one month last fall.
- HCCA Holdings' revenue grew by more than 250% year over year with some subsidiaries growing by more than 400%